Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
70 Cards in this Set
- Front
- Back
What is the staging for Neuroblastoma?
|
International Neuroblastoma Staging System (INSS); based on clinical, radiographic, and surgical evaluation
|
|
What is Stage I for neuroblastoma?
|
I: localized tumor with complete gross excision, w or w/o micro residual dz; negative ipsilateral LN microscopically (nodes attached to and removed with the primary tumor may be positive)
|
|
What is Stage II for neuroblastoma?
|
IIA: localized tumor with incomplete gross excision; ipsilateral nonadherent LN negative microscopically
IIB: localized tumor with or w/o complete gross excision; positive ipsilateral nonadherent LN; enlarged contralateral LN must be negative |
|
What is Stage III for neuroblastoma?
|
III: Unresectable unilateral tumor infiltrating across the midline, -/+ LN involvement; localized unilateral tumor with contralateral regional LN +; or midline tumor w bilateral extension by infiltration (unresectable) or by LN +
|
|
What is Stage IV for neuroblastoma?
|
IV: Any primary tumor with dissemination to distant LN, bone, bone marrow, liver, skin, and/or other organs
IV-S: localized primary tumor (as defined for stage I, IIA, IIB), with dissemination limited to skin, liver, and/or bone marrow (< 10% tumor) in infants < 1 yr of age |
|
What is neuroblastoma derived from?
|
Most common extracranial solid tumor of childhood. Derived from neural crest cells that form the adrenal medulla and sympathetic chain.
|
|
What chromosomal deletion is associated with neuroblastoma?
|
deletion of short arm of chromosome 1 (70-80% of patients): it is a poor prognostic marker
|
|
What are 2 poor prognostic indicators for neuroblastoma?
|
1. deletion of short arm chromosome 1 (70-80% patients)
2. amplification of N-myc oncogent |
|
How often is metastasis present at dx in neuroblastoma?
|
70%: most commonly in long bones and skull
|
|
Paraneoplastic syndromes in neuroblastoma:
|
1. catecholamine: mimic pheo
2. vasoactive intestinal polypeptide (VIP) 3. acute myoclonic encephalopathy |
|
Urinary metabolites of catecholamines in neuroblastoma:
|
vanillylmandelic acid and homovanillic acid 90-95% of patients
|
|
What are the prognostic factors in neuroblastoma?
|
1. Age: infants < 1 better survival
2. Site: nonadrenal primaries better 3. Stage: overall survival stages 1, 2, or 4S 75-90%; 2yr survival for stage 4 = 19-30% 4. N-myc: rapid tumor progression and poor prognosis 30-40% with advanced dz (independent risk factor) |
|
What are the Tx for neuroblastoma?
|
1. Surgery: >90% survival stage 1; defer until after chemotx for advanced dz
2. ChemoTx 3. XRT: no benefit for low stage; inc local control in advanced stage 4 or bulky stage 3 |
|
What is the most common soft tissue sarcoma in infants and children?
|
Rhabdomyosarcoma (RMS)
|
|
Most common GU sites for RMS?
|
15-20% of cases arise from GU system: prostate, bladder, paratesticular
|
|
Age distribution for RMS?
|
peak first 2 yrs and again at adolescence (bimodal)
|
|
What is the Li-Fraumeni syndrome?
|
-rare autosomal dominant d/o greatly inc susceptibility to cancer
-mutation of p53 tumor suppressor gene -assoc b/w childhood sarcomas with moms who have premenopausal breast cancer and with siblings who have inc risk of cancer |
|
T/F: Neurofibromatosis is assoc with increased incidence of RMS.
|
True
|
|
Most common subtype of RMS?
|
-embryonal RMS: arising from muscle grps (solid)
-sarcoma botryoides: polypoid variety develops in hollow organs or body cavities (i.e. bladder, vagina) -spindle cell (leiomyomatous): paratesticular region -botryoid and spindle cell: excellent survival -LOH on chormo 11p15 --> overexpression of IGF-II --> tumor growth |
|
Alveolar RMS:
|
-more commonly trunk and extremity
-worse prognosis: higher rate recurrence and mets -chromo translocations: t(1;13), PAX7-FKHR younger, better prognosis t(2;13), PAX3-FKHR adverse prognosis |
|
T/F: RMS extension to regional LN is uncommon.
|
False
|
|
Usual site of mets for RMS?
|
lungs
|
|
What is the "bladder sparing" approach to RMS Tx?
|
Both chemoTx and XRT before surgical resection
-60% retained bladder function at 4 yrs from dx -overall survival > 85% |
|
What is an exception to "bladder sparing" approach to RMS?
|
tumors amenable to partial cystectomy at dx (dome or lateral bladder wall)
|
|
Paratesticular RMS:
|
-distal portion of spermatic cord
-unilateral painless scrotal swelling -dx SUS |
|
T/F: RMS extension to regional LN is uncommon.
|
False
|
|
Usual site of mets for RMS?
|
lungs
|
|
What is the "bladder sparing" approach to RMS Tx?
|
Both chemoTx and XRT before surgical resection
-60% retained bladder function at 4 yrs from dx -overall survival > 85% |
|
What is an exception to "bladder sparing" approach to RMS?
|
tumors amenable to partial cystectomy at dx (dome or lateral bladder wall)
|
|
Paratesticular RMS:
|
-distal portion of spermatic cord
-unilateral painless scrotal swelling -dx SUS |
|
What stage is paratesticular RMS typically? What type of RMS?
|
60-80 are stage I; >90% embryonal and have a good prognosis; alveolar histology has better prognosis vs alveolar at other sites
|
|
How often is there RLN mets with paratesticular RMS?
|
20%
|
|
What surgical approach for paratesticular RMS?
|
Radical inguinal orchiectomy
|
|
When to do RPLND in paratesticular RMS?
|
children > 10 yo for ipsilateral RPLND as part of staging before chemoTx (higher risk for RP relapse and worse overall survival)
|
|
Why is RPLND in paratest RMS controversial?
|
morbid surgery, false-pos rate 65-94%, chemoTx is effective in microscopic nodal dz
|
|
What is survival rate for paratest RMS?
|
multimodal Tx survival 90%; pts with clinically negative nodes treated with chemo
|
|
Where does vaginal RMS usually occur?
|
anterior vaginal wall at the embryonic vesicovaginal septum (urogenital sinus)
|
|
Histologic type of vaginal RMS? Vulvar RMS?
|
embryonal or botryoid: excellent prognosis
Vulvar: alveolar, but good prognosis bc tends to be localized |
|
Tx for vaginal/vulvar RMS?
|
chemoTx +/- XRT --> repeat bx to assis response before delayed tumor resection (partial vaginectomy or vaginectomy with hysterectomy)
|
|
Histology for uterine RMS?
|
>90% embryonal
|
|
Tx for uterine RMS?
|
primary chemoTx and delayed local Tx
|
|
What is the most common primary malignant renal tumor of childhood? What is it derived from?
|
Wilms' tumor: embryonal tumor from remnants of immature kidney
|
|
Incidence of Wilms' tumor?
|
children <15yrs 7-10 per million
|
|
Median age for Wilms' tumor?
|
3.5 yrs; earlier age in males than females
|
|
Syndromes associated with Wilms' tumor?
|
1. Denys-Drash
2. WAGR 3. Horseshoe kidney (7fold risk) 4. Beckwith-Wiedemann 5. renal fusion anomalies, cryptorchidism, HPS |
|
What is Denys-Drash syndrome?
|
male pseudohermaphroditism, renal mesangial sclerosis, nephroblastoma; most progress to ESRD; mutation 11p13 (WT1)
|
|
What is Beckwith-Wiedemann syndrome (BWS)?
|
excess growth at the cellular, organ (macroglossia, nephromegaly, hepatomegaly) or body segment (hemihypertrophy)
|
|
Risk of Wilms' tumor with BWS and hemihypertrophy?
|
4-10% with 21% bilateral
|
|
T/F: Children with BWS and nephromegaly have the greatest risk for Wilms' tumor?
|
True
|
|
What is WAGR syndrome?
|
Wilms' tumor, Aniridia, Genital anomalies, mental Retardation: most likely to have bilateral Wilms' tumor and at younger age; prone to renal failure if survive to puberty
|
|
What is WT1?
|
located on 11p13, encodes transcription factor for gene regulation during normal renal and gonadal development; loss of one copy = WAGR syndrome; dysfcn WT1 protein = Denys-Drash
|
|
What is WT2?
|
11p15, assoc with BWS
|
|
Familial Wilms' tumor:
|
1-2%; earlier age of onset, inc freq for bilateral dz;
FWT1: 17q FWT2: 19q |
|
Other chromosomal abnormalities in Wilms' tumor?
|
16q in 20%
1p 10% Both with inc risk for relapse and death |
|
"Classic" Wilms' tumor histology:
|
favorable histology: islands of compact, undiff blastema and the presence of variable epithelial diff in the form of embryonic tubules, rosettes, and glomeruloid structures separated by a significant stromal component (Triphasic)
|
|
Anaplastic Wilms' tumor:
|
nuclear enlargement, hyperchromasia of enlarged nuclei, abn mitotic figures
-rarely seen in kids <2yo -assoc with resistance to chemoTx |
|
Nephrogenic rests:
|
> 1/3 of resected Wilms' tumor has these precursor lesions
|
|
Two categories of nephrogenic rests:
|
1. Perilobar (PLNR): BWS (WT2, 11p15); higher risk of contralateral dz in kids < 12mos
2. Intralobar (ILNR): aniridia, DDS (WT1, 11p13) |
|
What is nephroblastomatosis?
|
presence of multiple nephrogenic rests; diffuse overgrowth of PLNR can produce thick rind that enlarges the kidney, but preserves its original shape; prone to favorable histology Wilms' tumor and bilateral tumors
|
|
Common locations for mets in Wilms' tumor (most to least common):
|
pulmonary, hepatic, bone, rarely brain
|
|
Is exploration of the contralateral kidney necessary in Wilms' tumor?
|
No, if preoperative CT or MRI demonstrates normal kidney
|
|
When is preoperative chemoTx recommended for Wilms' tumor?
|
1. bilateral Wilms' tumor (initial bx then preop chemo)
2. inoperable tumors at surgical exploration 3. tumor extension into IVC above hepatic veins |
|
Poor prognostic chromosomal factors for Wilms' tumor?
|
LOH for 16q (poorer 2 yr relapse free and overall survival rates);
LOH at either 1p or 16q with stage I or II have inc relative risk of relapse and death; With stage III or IV tumors risk of relapse and death increased in LOH at both 1p and 16q |
|
Tx of bilateral Wilms' tumor:
|
5% of children; initial bx followed by 6wks of chemoTx; repeat imaging then partial nephx during 2nd look; close long-term FU
|
|
Tx if inoperable (Stage III) Wilms' tumor:
|
pretreatment with chemo 6wks almost always makes tumor resectable
|
|
What is the most common testis tumor in prepubertal children?
|
Mature teratoma: benign clinical course; all 3 germ cell layers; testis sparing enucleation of mass
|
|
What is the 2nd most common testis tumor in prepubertal children?
|
yolk sac tumor; characteristic Schiller-Duval bodies; 90% pos AFP
|
|
Leydig cell tumors:
|
Reinke's crystals pathognomonic; precocious puberty; most common sex cord tumor; age 4-5; inguinal orchiectomy
|
|
What is the most common tumor found in assoc with intersex d/o?
|
gonadoblastoma: occurs in dysgenetic gonads and assoc with Y chromosome; 1/3 bilateral; 25% risk in mixed gonadal dysgenesis, incidence inc with age; germ cell degeneration into seminoma or nonseminomatous tumors; ALL streak gonads in gonadal dysgenesis should be removed
|
|
What is the most common malignancies that spread to the testis in children?
|
Leukemia (ALL) and lymphoma (follicular and Burkitt's)
|